Selecting the best research

Prostate Cancer Canada has a proud history of funding research that generates new knowledge in the areas of prevention, diagnosis, treatment and survivorship. This knowledge is helping to save and improve more lives.

Dr. Laurence Klotz, a member of the team that received Prostate Cancer Canada’s first research grant in 1996 and now a renowned researcher, says:

“It’s a completely different environment now than 1996. We have many internationally-renowned researchers and I don’t think there’s any other country of comparable size that has achieved such stature in prostate cancer research. This is very much due to the ongoing support of Prostate Cancer Canada which has made funding available for a lot of talented people to carry out their research that has been extremely productive, resulting in advances in management of the disease.”

But as long as an average of 11 Canadian men die of prostate cancer every day, we cannot stop.

Research is the engine of new knowledge that leads to better detection and treatments. It helps us save and improve more lives. Prostate Cancer Canada invests in Canada’s most promising studies and minds. Every year, we ask Canadian researchers to submit new ideas for research projects. Our rigorous review process ensures that Prostate Cancer Canada invests in Canada’s most promising studies and minds by bringing in expert input from leading scientists from Canada and around the world.


Following this step, our Research Advisory Council makes funding recommendations. The Research Advisory Council also provides its expert advice to help Prostate Cancer Canada have the highest quality research program possible.

Alison Allan, Western University, London, ON
David Berman, (Scientific Chair) Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, University of California, Los Angeles, CA, USA
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC 
Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Anne Katz, Manitoba Prostate Centre, Winnipeg, MB
Winston Klass, Community Representative, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Mathieu Lupien, Princess Margaret Cancer Centre, Toronto, ON
Cynthia Ménard, Centre hospitalier de l'Université de Montréal, Montreal, QC
Ian G. Mills, Queen's University Belfast, Belfast, UK
Fred Saad, Université de Montréal, Montreal, QC
Danny Vesprini, Sunnybrook Research Institute, Toronto, ON
Katherine Zukotynski, McMaster University, Hamilton, ON


As of July 2019

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive